Showing results (1681-1690 of 3,353) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|July 18, 2001
International validation of the CLAU-S quality-of-life questionnaire for use in patients with intermittent claudicationP Marquis, S Comte, P LehertPharmacoeconomics|October 13, 2001
Cost-efficacy analysis of fluticasone propionate versus zafirlukast in patients with persistent asthmaR Menendez, R H Stanford, L Edwards, et al.Pharmacoeconomics|October 13, 2001
Cost-effectiveness analysis of dopamine agonists in the treatment of Parkinson's disease in JapanT Shimbo, K Hira, M Takemura, et al.Pharmacoeconomics|September 18, 2003
Prevention of recurrent rhinopharyngitis in at-risk children in France: a cost-effectiveness model for a nonspecific immunostimulating bacterial extract (OM-85 BV)Jean-Jacques Pessey, Françoise Mégas, Benoît Arnould, et al.Pharmacoeconomics|April 17, 2003
Pharmaceutical care programmes for the elderly: economic issuesGrainne E Crealey, Ian K Sturgess, James C McElnay, et al.Pharmacoeconomics|April 17, 2003
Cytomegalovirus infection in solid organ transplantation: economic implicationsAnanya DasPharmacoeconomics|January 8, 2003
Discounting in cost-utility analysis of healthcare interventions: reassessing current practiceBrian J CohenPharmacoeconomics|January 8, 2003
Cost of illness of atopic dermatitis in children: a societal perspectiveAndrew S KempPharmacoeconomics|January 8, 2003
Cost analysis of ropinirole versus levodopa in the treatment of Parkinson's diseaseMichael Iskedjian, Thomas R EinarsonPharmacoeconomics|April 17, 2003
Measuring the outcomes and pharmacoeconomic consequences of venous thromboembolism prophylaxis in major orthopaedic surgerySean D Sullivan, Susan R Kahn, Bruce L Davidson, et al.Pageof 336